CD117 IHC showed that PsA patients are characterized by higher IHC scores for CD117+ cells (1.25 ± 0.61) compared to Abneg RA patients (0.62 ± 0.46, p < 0.001) regardless of the treatment scheme (Fig. 3a–d). This evidence concerns the gene KIT and rheumatoid arthritis.